TITLE

The Role of Androgen and Its Receptor in Ovary

AUTHOR(S)
WANG Fang-fang; PAN Jie-xue; REN Jun; HUANG He-feng
PUB. DATE
February 2014
SOURCE
Journal of International Obstetrics & Gynecology;Feb2014, Vol. 41 Issue 1, p14
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Androgen mediate their action primarily via transcriptionally activating the androgen receptor (AR),an important factor of androgen signaling pathway. The roles of androgen and AR in female reproductive physiology arise from their biological effect on follicle growth and development both in vitro and in vivo. Although the pivotal role of androgen in male reproductive function is well established, the precise mechanism of it in female reproductive physiology and pathology remains blurred. Recent studies have established several animal models with specific disruption of the AR gene, and this helps us understand the role of AR -mediated action in maintaining female fertility. Here we reviewed androgen and AR signaling pathway in ovary.
ACCESSION #
97776481

 

Related Articles

  • Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. Lee, Eugine; Ha, Susan; Logan, Susan K. // PLoS ONE;10/28/2015, Vol. 10 Issue 10, p1 

    Despite decades of effort to develop effective therapy and to identify promising new drugs, prostate cancer is lethal once it progresses to castration-resistant disease. Studies show mis-regulation of multiple pathways in castration-resistant prostate cancer (CRPC), reflecting the heterogeneity...

  • Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer. Jalava, S E; Urbanucci, A; Latonen, L; Waltering, K K; Sahu, B; Jänne, O A; Seppälä, J; Lähdesmäki, H; Tammela, T L J; Visakorpi, T // Oncogene;10/11/2012, Vol. 31 Issue 41, p4460 

    The androgen receptor (AR) signaling pathway is involved in the emergence of castration-resistant prostate cancer (CRPC). Here, we identified several androgen-regulated microRNAs (miRNAs) that may contribute to the development of CRPC. Seven miRNAs, miR-21, miR-32, miR-99a, miR-99b, miR-148a,...

  • Molecular aspects of prostate cancer. Cronauer, M.; Culig, Z. // World Journal of Urology;Jun2012, Vol. 30 Issue 3, p277 

    No abstract available.

  • NF-κB signaling in prostate cancer: A promising therapeutic target? Jain, Garima; Cronauer, Marcus; Schrader, Mark; Möller, Peter; Marienfeld, Ralf // World Journal of Urology;Jun2012, Vol. 30 Issue 3, p303 

    Prostate carcinoma (PCa) displays a wide variety of genetic alterations, versatile expression profiles as well as cell surface markers. Despite this heterogeneity, a common treatment for advanced PCa is androgen deprivation therapy (ADT). ADT targets the androgen receptor-a member of the nuclear...

  • Androgen receptor footprint on the way to prostate cancer progression. Hodgson, Myles; Bowden, Wayne; Agoulnik, Irina // World Journal of Urology;Jun2012, Vol. 30 Issue 3, p279 

    The prostate gland is exquisitely sensitive to androgen receptor (AR) signaling. AR signaling is obligatory for prostate development and changes in AR levels, its ligands or shifts in AR mode of action are reflected in the physiology of the prostate. The AR is intimately linked to prostate...

  • Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Chang, C.; Lee, S. O.; Yeh, S.; Chang, T. M. // Oncogene;6/19/2014, Vol. 33 Issue 25, p3225 

    The androgen receptor (AR) is expressed in many cell types and the androgen/AR signaling has been found to have important roles in modulating tumorigenesis and metastasis in several cancers including prostate, bladder, kidney, lung, breast and liver. However, whether AR has differential roles in...

  • Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer. Ha, S; Iqbal, N J; Mita, P; Ruoff, R; Gerald, W L; Lepor, H; Taneja, S S; Lee, P; Melamed, J; Garabedian, M J; Logan, S K // Oncogene;8/22/2013, Vol. 32 Issue 34, p3992 

    Integration of cellular signaling pathways with androgen receptor (AR) signaling can be achieved through phosphorylation of AR by cellular kinases. However, the kinases responsible for phosphorylating the AR at numerous sites and the functional consequences of AR phosphorylation are only...

  • Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer. McBeth, Lucien; Grabnar, Maria; Selman, Steven; Hinds, Terry D. // International Journal of Endocrinology;8/10/2015, Vol. 2015, p1 

    Bladder cancer is encountered worldwide having been associated with a host of environmental and lifestyle risk factors. The disease has a male to female prevalence of 3 : 1. This disparity has raised the possibility of the androgen receptor (AR) pathway being involved in the...

  • AR function in promoting metastatic prostate cancer. Augello, Michael; Den, Robert; Knudsen, Karen // Cancer & Metastasis Reviews;Sep2014, Vol. 33 Issue 2/3, p399 

    Prostate cancer (PCa) remains a leading cause of cancer-related death in the USA. While localized lesions are effectively treated through radical prostatectomy and/or radiation therapy, treatment for metastatic disease leverages the addiction of these tumors on the androgen receptor (AR)...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics